Story at a glance Cervical cancer rates, long on the decline, are climbing among low-income women in the United States. Cervical cancer was once the leading cause of death for American women, according to the American Cancer Society. But incidence and mortality rates for the disease have significantly dropped in recent decades thanks to…
(Reuters) -A decline in prostate cancer screening has been linked to subsequent increases in advanced cancers, according to data from the U.S. Department of Veterans Affairs (VA), findings that may spur revisiting current U.S. testing guidelines. "Screening rates were significant predictors of metastatic cancer rates," study leader Dr. Brent Rose of the University of California, San Diego said at a news conference on Monday at the annual meeting of the American Society for Radiation Oncology (ASTRO) in San Antonio, Texas. The benefits of screening for prostate cancer have been controversial.
Cancer screening rates have largely remained below pre-pandemic levels at least through early 2021, but health providers are taking aim at reducing the deficit.